News

NICE has recommended mogamulizumab for the treatment of relapsed or refractory mycosis fungoides or Sézary syndrome

If you were employed during or after treatment for lymphoma, get involved in a study looking at the challenges faced by people managing work and cancer. 

The Scottish Medicines Consortium has expanded access to pembrolizumab on the NHS in Scotland.

'Most of us are good at asking how others are, but it can be hard to start talking about how you feel and what you are worried about.'

Many lymphomas have very complicated names. Can you explain how lymphomas are given their names?

You are recommended to have an annual influenza or 'flu jab' if you have lymphoma. Find out more.

Avelumab is well tolerated and has shown early evidence of activity against relapsed or refractory Hodgkin lymphoma.

In collaboration with 50 other cancer charities, we have written to the Government to ask that they take action at the next Comprehensive Spending Review, and respond urgently to the challenges faced by cancer services.  

Today is World Mental Health Day, and an opportunity to focus on our emotional and mental wellbeing. We have some resources that you may find helpful.

Epcoritamab has produced promising results in an early phase clinical trial.